Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana has been recognized as the leading insurance company for Medicare Advantage plans in 2023 by U.S. News & World Report, excelling in three key categories: overall rating, member experience, and low-premium plan availability.
With 4.9 million members, or 96%, enrolled in plans rated 4 stars and above, Humana emphasizes quality care and customer service. The recognition follows a strong performance in CMS Star ratings, which evaluate plans on a 1-to-5 star scale. Humana’s commitment to enhancing health outcomes for Medicare beneficiaries has helped solidify its top position in the industry.
CenterWell Senior Primary Care is set to launch three new primary care centers in Louisville, Kentucky, enhancing access to senior-focused healthcare. These centers, part of CenterWell's expansion plan, will incorporate a team-based approach to care. With over 220 centers currently operational, they plan to open 30-50 more annually by 2025. A notable community contribution includes $20,000 donated to local non-profits. The first center began operating on October 24, with upcoming openings on November 21 and January 17.
AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana Inc. (HUM) for its $500 million of 5.75% senior unsecured notes due March 1, 2028, and $750 million of 5.875% senior unsecured notes due March 1, 2033. The outlook for the ratings is stable. Proceeds are expected to refinance $1 billion in debt due in December and for general corporate purposes. Humana maintains a financial leverage of 41%, which is in line with industry standards, while targeting a debt-to-capital ratio below 40%.
Humana Inc. (NYSE: HUM) has priced a public offering of $1.25 billion in senior notes, including $500 million of 5.75% notes due 2028 and $750 million of 5.875% notes due 2033. The offering is set to close on November 22, 2022. The expected net proceeds of approximately $1.232 billion will be used to repay existing senior notes due in December 2022 and for general corporate purposes. The offerings are made under an effective shelf registration statement with the SEC.
Humana Inc. (NYSE: HUM) reported 3Q22 GAAP EPS of $9.39 and adjusted EPS of $6.88, with YTD 2022 GAAP EPS at $22.16 and adjusted EPS at $23.58. The company raised FY 2022 guidance to approximately $23.27 GAAP EPS and affirmed an adjusted EPS target of $25.00, showing 21% growth from FY 2021. Humana leads in Medicare Advantage Star ratings, with 96% of members in contracts rated 4 stars or higher. It expects growth of 325,000 to 400,000 Medicare Advantage members in 2023, aligning with industry trends.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, payable on January 27, 2023, to stockholders recorded as of the close on December 30, 2022. This decision reflects Humana's commitment to returning value to its shareholders while promoting integrated healthcare solutions through various clinical capabilities. The company continues to prioritize the well-being of its members, which include individuals, families, and military personnel, by simplifying healthcare access and improving quality of life.
Humana Inc. (NYSE: HUM) and Monogram Health have entered a new value-based care agreement for Humana Medicare Advantage members with chronic kidney disease in Tennessee, Alabama, Mississippi, and Louisiana. This collaboration emphasizes coordinated care and provides specialized resources, including in-home services and medication management, to enhance members' quality of life. Humana reports over 3.2 million members engaged in value-based care as of June 30, 2022, and a total Medicare Advantage membership of approximately 5.1 million.
Humana Inc. (NYSE: HUM) is enhancing its Medicare offerings by launching Medicare Advantage plans for the first time in Rhode Island and Wyoming, expanding access to over 140 U.S. counties.
This expansion will allow Medicare beneficiaries to enroll in Humana plans during the Annual Election Period from now until December 7, with plans effective from January 1. Humana aims to improve affordability and access with a significant increase in $0 premium plans, which will be available to 69% of prospective members.
Cohere Health announced an expansion of its partnership with Humana Inc. (NYSE: HUM) to enhance prior authorization processes for cardiovascular and surgical services. Effective January 1, 2023, the technology aims to streamline workflows by automating clinical intelligence within provider practices. A pilot program showed a 34% faster authorization request process for participating providers, with 99% adoption rates and high satisfaction scores. This collaboration focuses on improving care quality and reducing administrative burdens, ultimately benefiting Humana's Medicare Advantage members.
Summary not available.